Cuny C, Eicher J C, Collet E, Chatard C, Chauffert B, Lorcerie B, Martin F, Wolf J E, Louis P
Service de Médecine Interne et Immunologie Clinique, Hôpital du Bocage, Dijon.
Ann Cardiol Angeiol (Paris). 1993 Mar;42(3):155-8.
Cardiac involvement in dermatopolymyositis is common but rarely symptomatic. Cardiac failure as the presentation is very rare. No correlation exists between the severity of muscular involvement and cardiac involvement. Myocarditis is not uncommon and must be borne in mind if CK MB are above 3% of total CK. It is always associated with electrocardiographic abnormalities. Corticosteroids remain first line treatment. They generally lead to regression of cardiac problems which are usually of secondary importance. If cardiac involvement is severe, the spectacular action of venoglobulins should lead to their use being envisaged from the outset, combined with corticosteroids.
心脏受累在皮肌炎中很常见，但很少有症状。以心力衰竭为表现的情况非常罕见。肌肉受累的严重程度与心脏受累之间不存在相关性。心肌炎并不少见，如果肌酸激酶同工酶（CK MB）高于总肌酸激酶（CK）的3%，则必须考虑到心肌炎。它总是与心电图异常相关。皮质类固醇仍然是一线治疗方法。它们通常会使通常为次要问题的心脏问题得到缓解。如果心脏受累严重，静脉注射球蛋白的显著作用应促使从一开始就考虑使用，同时联合皮质类固醇。
